About the Risk of Development of Aneuploidy of Embryos Depending on Male Pathozoospermia in the Program of Assisted Reproductive Technologies
Abstract
Introduction: The issue of male infertility is becoming more and more relevant every day. According to various statistical sources, the male factor in the structure of infertility is currently 50-60. Although just a couple of decades ago, this figure was only 30 [3]. Considering the etiological and pathogenetic aspects of male infertility, it should be noted that we are talking not only about a quantitative change in the number and degree of sperm motility, but also about morphological, genetic and functional disorders [11].
References
Alvarez C., Garcia-Garrido C., Taronger R., Gonzalez de Merlo G. In vitro maturation, fertilization, embryo development &clinical outcome of human metaphase-I oocytes retrieved from stimulated intracytoplasmic sperm injection cycles. Indian J. Med. Res. 2013; 137(2):331-8.
Andersen C.Y., Andersen K.V. Improving the luteal phase after ovarian stimulation: reviewing new options. Reprod. Biomed. Online. 2014; 28(5):552-9.
Burnik Papler T., Vrtacnik Bokal E., Maver A., Lovrecic L. Specific gene expression differences in cumulus cells as potential biomarkers of pregnancy. Reprod. Biomed. Online. 2015; 30(4):426-33.
Elsayed G.M., El Assiouty L., El Sobky E.S. The importance of aneuploidy screening and prenatal diagnosis in the detection of numerical chromosomal abnormalities. Springerplus. 2013; 2:490
Fu W., Lu J., Xu L., Zheng L., Zhang Y., Zhong Y. et al. Applied research of combined G –banding and array-CGH in the prenatal diagnosis of ultrasonographic abnormalities in fetuses. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.2014; 31(6):737-42.
Gregg A.R.,Gross S.J., Best R.G., Monaghan K.G., Bajaj K., Skotko B.G. et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet.Med. 2013;15(5):395-8.
Leth-Moller K., Hammer Jagd S., Humaidan P. The luteal phase after GnRHa trigger-understanding an enigma. Int.J. Fertil. Steril.2014; 28(3):227-34.
Neyt M., Huistaeri F., Gyselaers W. Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis. BMJ Open. 2014;4(11): e005922.
Ong F.S.,Lin J.C., Das K.,Grosu D.S., Fan J.B. Translational utility of next-generation sequencing. Genomics. 2013; 102(3):137-9
Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil. Steril.2016; Sep 24.pii:S0015-0282(16)627-4. doi:10.1016 | j.fertnstert.2016.08.048.
Schatten H.,Qing-Yuan Sun, Prather R.The impact of mitochondrial function-dysfunction on IVF and new treatment possibilities for infertility. Reprod. Biol.Endocrinol. 2014; 12: 111.
Schmutzler A.G., Acar-Perk B., Weimer J., Salmassi A., Sievers K., Tobler M. et al. Oocyte morphology on day 0 correlates with aneuploidy as detected by polar body biopsy and FISH. Arch. Gynecol. Obstet. 2014; 289(2):445-50
Yang X., Huang R., Wang Y., Liang X. Pituitary suppression before frozen embryo transfer is beneficial for patients suffering from idiopathic repeated implantation failure. J.Huazhong Univ.Sci.Technolog. Med. Sci.2016; 36(1):127-31.
Keywords
azoospermia
in vitro fertilization (IVF) мужско бесплодие
азооспермия
экстра корпорального оплодотворения(ЭКО) kişi sonsuzluğu
azospermiya
in vitro gübrələmə (IVF)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.